John A. Laurie

6.3k total citations · 3 hit papers
30 papers, 4.7k citations indexed

About

John A. Laurie is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John A. Laurie has authored 30 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John A. Laurie's work include Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (9 papers) and Cancer Treatment and Pharmacology (6 papers). John A. Laurie is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (9 papers) and Cancer Treatment and Pharmacology (6 papers). John A. Laurie collaborates with scholars based in United States, United Kingdom and Canada. John A. Laurie's co-authors include C G Moertel, James E. Krook, Daniel G. Haller, John H. Glick, Harry S. Wieand, James A. Mailliard, Charles G. Moertel, Phyllis J. Goodman, Thomas R. Fleming and John S. Macdonald and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

John A. Laurie

29 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

1990 1.7k citations Charles G. Moertel, Thomas R. Fleming et al. New England Journal of Medicine profile →
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

1989 725 citations M. J. OʼConnell, C G Moertel et al. Journal of Clinical Oncology profile →
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

1989 526 citations John A. Laurie, C G Moertel et al. Journal of Clinical Oncology profile →

Peers

John A. Laurie

ONCOL

PFM

PRM

SURGE

HEPAT

Guido Francini Italy

Harry S. Wieand United States

Kanwal Raghav United States

Louise B. Grochow United States

Gilles Freyer France

Yasutsuna Sasaki Japan

John V. Cox United States

Christophe Borg France

J. Wils Netherlands

Valérie Jooste France

Guido Francini Italy

John A. Laurie

4.1k ×1.1

ONCOL

1.1k ×0.8

PFM

1.3k ×1.1

PRM

934 ×0.9

SURGE

203 ×0.6

HEPAT

Citations per year, relative to John A. Laurie John A. Laurie (= 1×) peers Guido Francini

Countries citing papers authored by John A. Laurie

Since Specialization

Citations

This map shows the geographic impact of John A. Laurie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Laurie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Laurie more than expected).

Fields of papers citing papers by John A. Laurie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Laurie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Laurie. The network helps show where John A. Laurie may publish in the future.

Co-authorship network of co-authors of John A. Laurie

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Laurie. A scholar is included among the top collaborators of John A. Laurie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Laurie. John A. Laurie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fenger‐Eriksen, Christian, Kirsten Christiansen, John A. Laurie, Benny Sørensen, & Catherine Rea. (2013). Fibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution. Thrombosis Research. 131(5). e210–e213. 15 indexed citations

Sinicrope, Frank A., Rafaela L. Rego, Kevin C. Halling, et al.. (2006). Prognostic Impact of Microsatellite Instability and DNA Ploidy in Human Colon Carcinoma Patients. Gastroenterology. 131(3). 729–737. 177 indexed citations

Sloan, Jeff A., Daniel J. Sargent, Cristine Allmer, et al.. (2002). A new graphic for quality adjusted life years (Q-TWiST) survival analysis: The Q-TWiST plot. Quality of Life Research. 11(1). 37–45. 9 indexed citations

OʼConnell, M. J., John A. Laurie, Michael Kahn, et al.. (1998). Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.. Journal of Clinical Oncology. 16(1). 295–300. 289 indexed citations

Peethambaram, Prema P., Matthias Weiß, Charles L. Loprinzi, et al.. (1997). An Evaluation of Postoperative Follow-Up Tests in Colon Cancer Patients Treated for Cure. Oncology. 54(4). 287–292. 24 indexed citations

Loprinzi, Charles L., Mary C. Hill, Paula J. Schomberg, et al.. (1996). Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. International Journal of Radiation Oncology*Biology*Physics. 36(2). 345–349. 192 indexed citations

Loprinzi, Charles L., John A. Laurie, Harry S. Wieand, et al.. (1994). Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.. Journal of Clinical Oncology. 12(3). 601–607. 220 indexed citations

Moertel, C G, Thomas R. Fleming, J. S. Macdonald, Daniel G. Haller, & John A. Laurie. (1993). Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.. Journal of Clinical Oncology. 11(12). 2386–2390. 87 indexed citations

Brindle, Jeffrey, et al.. (1993). Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma. Cancer. 72(2). 405–409. 13 indexed citations

10.

Laurie, John A., Richard G. Hahn, Terry M. Therneau, et al.. (1992). Chemotherapy for hormonally refractory advanced prostate carcinoma. A Comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil. Cancer. 69(6). 1440–1444. 23 indexed citations

11.

Long, Harry J., John A. Laurie, Harry S. Wieand, et al.. (1991). A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the north central cancer treatment group and the mayo clinic. Cancer. 68(4). 730–732. 1 indexed citations

12.

Morton, Roscoe F., James R. Jett, William L. McGinnis, et al.. (1991). Thoracic Radiation Therapy Alone Compared with Combined Chemoradiotherapy for Locally Unresectable Non-Small Cell Lung Cancer. Annals of Internal Medicine. 115(9). 681–686. 140 indexed citations

13.

Windschitl, Harold E., Harry S. Wieand, James E. Krook, et al.. (1990). A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer. Cancer. 66(5). 853–856. 7 indexed citations

14.

Moertel, Charles G., Thomas R. Fleming, John S. Macdonald, et al.. (1990). Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma. New England Journal of Medicine. 322(6). 352–358. 1722 indexed citations breakdown →

15.

Everson, Lloyd K., James R. Jett, Judith R. OʼFallon, et al.. (1989). Alternating Chemotherapy With or Without VP-16 in Extensive-Stage Small-Cell Lung Cancer. American Journal of Clinical Oncology. 12(4). 339–344. 8 indexed citations

16.

Laurie, John A., C G Moertel, Thomas R. Fleming, et al.. (1989). Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.. Journal of Clinical Oncology. 7(10). 1447–1456. 526 indexed citations breakdown →

17.

Edmonson, J H, Harry S. Wieand, J. W. Kugler, et al.. (1989). Cyclophosphamide-Cisplatin Versus Cyclophosphamide-Carboplatin in Stage III-IV Ovarian Carcinoma: A Comparison of Equally Myelosuppressive Regimens. JNCI Journal of the National Cancer Institute. 81(19). 1500–1504. 44 indexed citations

18.

Marschke, Robert F., Larry K. Kvols, Stephen A. Cullinan, et al.. (1988). Phase II study of bisantrene administered by continuous 72‐hour infusion for advanced pancreatic adenocarcinoma. Medical and Pediatric Oncology. 16(4). 269–270. 2 indexed citations

19.

Buroker, T, C G Moertel, Thomas R. Fleming, et al.. (1985). A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.. Journal of Clinical Oncology. 3(12). 1624–1631. 90 indexed citations

20.

Krook, James E., James R. Jett, Thomas R. Fleming, et al.. (1985). A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 3(6). 842–848. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact